A Major Milestone For Gene Editing To Treat Cancer- New Study Finds CRISPR Can Successfully Kill Cancer Cells Without an Adverse Affect on Patients

Published Feb 7, 2020

A Major Milestone For Gene Editing To Treat Cancer- New Study Finds CRISPR Can Successfully Kill Cancer Cells Without an Adverse Affect on Patients

Overseen by the renowned immunologist Dr. Carl June, it showed the edited genes had a sustained ability to attack and kill tumors.

NOW
PLAYING
Quarantine Guideline Changes From CDC May Be Coming & Mayo Clinic to Share New Data About Value of Masks During COVID-19
NOW
PLAYING
From COVID-19 to Cancer, Could mRNA Carry the Answer?
NOW
PLAYING
Why Clinical Trials for Diffuse Large B-Cell Lymphoma Are So Important
NOW
PLAYING
Don't Wait Too Long to Consider CAR T-Cell Therapy
NOW
PLAYING
CAR T-Cell Therapy for Non-Hodgkin Lymphoma
NOW
PLAYING
Given Just 18 Months to Live, This Lung Cancer Survivor Proves the Power of Clinical Trials

SurvivorNetTV.
Hope. Science.
Inspiration.

Discover SNTV
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.